Clinical trial · Observational
Skin Cancer Oncology Radiation Evidence Registry
NCT04681456CI-TRIAL-00051805SCORERterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The study was stopped in order to reconfigure it as a PhaseII/III study
Summary
Brief summary (as posted)
To collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer. A target of 400 VMAT-treated sites is set which is estimated to be identified in approximately 350 participants. Participants referred for radiotherapy for the management of non-melanoma skin cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-melanoma Skin Cancer | Skin Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| There is no medical intervention for the purposes of this Registry. | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Participants will have their responses to radiotherapy after treatment of non-melanoma skin cancer measured and reported as number of participants with treatment-related adverse events as assessed by CTCAE v4.0.
- timeFrame
- 5 years
- description
- To assess participant safety following treatment of non-melanoma skin cancers with radiotherapy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years of age * Diagnosed with a treatable non-melanoma skin cancer by referring medical practitioner * Eligible to be treated using widefield (\>50cm2) VMAT radiotherapy as determined by RO * Patient has provided written informed consent. Exclusion Criteria: ♦ Patients who do not consent to their involvement in the Registry.
References
Publications (0)
Data not yet available
No reference posted for this study.